Venture capital investment manager Deepbridge Capital has completed its latest Life Sciences SEIS GBP1 million funding round.
Companies receiving seed-stage funding include Carocell Bio, Circada, FlutterLab, GenoMe Diagnostics, Glucose Republic and NanOptima.
The Deepbridge Life Sciences SEIS enables private investors to access a portfolio of early-stage companies within the UK’s vibrant life sciences sector, whilst benefiting from the generous potential tax reliefs available via the Government’s Seed Enterprise Investment Scheme (SEIS).
Deepbridge also manages the Deepbridge Life Sciences EIS, the Deepbridge Technology Growth EIS and the Deepbridge Innovation SEIS.
Read more/Source: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.